Bruxism: Causes, Symptoms & Treatment

Introduction and Definition of Bruxism

Bruxism is formally defined as a repetitive jaw-muscle activity characterized by the clenching, bracing, gnashing, or grinding of the teeth, or by thrusting of the mandible. This behavior is classified as a parafunctional oral habit, meaning it involves the use of the oral structures for activities outside of their primary functions of speaking, chewing, and swallowing. While often perceived solely as a dental issue, bruxism is a complex biopsychosocial phenomenon involving interactions between central nervous system mechanisms, psychological states, and peripheral neuromuscular activity. The critical distinction in modern diagnostics lies in when the behavior occurs, separating it into two primary clinical phenotypes: awake bruxism (AB) and sleep bruxism (SB).

The prevalence of bruxism varies widely across populations, though estimates suggest that chronic, symptomatic sleep bruxism affects approximately 8% to 10% of the adult population, with higher rates observed in children and adolescents, often resolving spontaneously. The clinical significance of bruxism is determined by its frequency, duration, and the resulting damage. Mild or occasional bruxism may be benign, but severe, chronic manifestations lead to irreversible damage to dental structures, prosthetic restorations, and the supporting periodontium. Furthermore, chronic bruxism significantly contributes to the development and exacerbation of temporomandibular joint disorders (TMDs), chronic facial pain, and severe headaches, thus heavily impacting the patient’s quality of life.

Historically, bruxism was often categorized simplistically as a habit driven by malocclusion or local dental factors. However, contemporary research recognizes it primarily as a centrally mediated disorder. The International Classification of Sleep Disorders (ICSD-3) now classifies sleep bruxism as a specific sleep-related movement disorder, emphasizing its link to physiological arousal during sleep stages. Understanding bruxism requires a multidisciplinary approach, integrating findings from dentistry, sleep medicine, neurology, and psychology, particularly given the strong association between bruxism activity and psychological stress and emotional regulation difficulties.

Classification and Phenotypes

Modern clinical practice categorizes bruxism based on its temporal occurrence. Awake bruxism (AB) is characterized by semi-voluntary clenching and bracing of the jaw while the individual is conscious. This form rarely involves loud grinding sounds but typically manifests as sustained, isometric muscle contraction, often during periods of high concentration, stress, or when performing tasks requiring significant effort. Patients with AB may be unaware of the habit until they experience symptoms such as tension headaches or facial muscle fatigue, highlighting the often-subconscious nature of this sustained muscular activity.

Sleep bruxism (SB), conversely, is an involuntary activity occurring during sleep and is characterized by rhythmic (grinding) or tonic (clenching) muscle contractions. SB is closely linked to micro-arousals—brief shifts in autonomic nervous system activity—that occur frequently throughout the non-REM sleep cycle, particularly in stages N1 and N2. These events are often quantified as rhythmic masticatory muscle activity (RMMA). The forceful rubbing or grinding observed in SB generates significant occlusal forces, which can be far greater than those exerted during normal chewing, accounting for the severe dental attrition commonly seen in chronic sleep bruxers.

Further subclassification differentiates between primary (idiopathic) and secondary bruxism. Primary bruxism occurs without an identifiable underlying medical or psychological cause, suggesting an inherent dysfunction in the central nervous system regulation of motor activity. Secondary bruxism is associated with specific underlying conditions, which may include the use of certain psychotropic medications (such as selective serotonin reuptake inhibitors, or SSRIs), neurological disorders (e.g., Parkinson’s disease, Huntington’s disease), or the presence of other sleep disorders, most notably obstructive sleep apnea (OSA). The distinction between primary and secondary forms is critical for determining the most appropriate and effective therapeutic strategy.

Etiology and Contributing Factors

The etiology of bruxism is multifactorial, involving a complex interplay of central, psychological, and peripheral mechanisms. The prevailing hypothesis points toward a central nervous system origin, suggesting that bruxism activity is regulated by the brainstem’s central pattern generator (CPG), which controls rhythmic movements like chewing. Dysregulation of this CPG, potentially mediated by fluctuations in neurotransmitter levels—particularly dopamine and serotonin—is thought to trigger the micro-arousals during sleep, subsequently initiating the forceful masticatory muscle contractions characteristic of SB. This neurological explanation accounts for the involuntary and rhythmic nature of the disorder.

Psychological factors represent a highly significant, often dominant, contributing element, especially in awake bruxism and the exacerbation of sleep bruxism severity. High levels of chronic psychological stress, anxiety, and personality traits such as competitiveness, aggression, and obsessive-compulsive tendencies are strongly correlated with increased bruxism activity. Stress translates into increased physiological tension, leading to elevated muscle tonus in the jaw and neck musculature. Patients often report clenching their teeth during periods of professional pressure or emotional distress, indicating that bruxism serves as a physical manifestation or outlet for pent-up psychological energy.

Beyond central and psychological influences, various systemic and exogenous factors can contribute to or intensify bruxism. Lifestyle habits such as excessive consumption of caffeine, alcohol, and tobacco products, particularly before sleep, have been consistently linked to increased bruxism episodes due to their stimulating effects on the nervous system and their ability to disrupt sleep architecture. Furthermore, certain classes of medications, including antidepressants (especially SSRIs and SNRIs), stimulants (e.g., those used for ADHD treatment), and recreational drugs, are known to induce or worsen bruxism as a side effect, necessitating careful pharmacological management and monitoring when these drugs are prescribed.

Clinical Manifestations and Sequelae

The physical consequences of chronic bruxism are extensive and primarily affect the dental and musculoskeletal systems. The most immediate and common clinical sign is dental attrition, characterized by excessive wear of the occlusal surfaces of the teeth, leading to flattened cusps and sharp enamel edges. In severe cases, attrition can expose the underlying dentin, accelerating wear and potentially leading to pulpal pathology and sensitivity to thermal changes. Bruxism forces can also cause microfractures in enamel, chipping of tooth structure, fracture of existing dental restorations, and increased tooth mobility due to excessive forces placed on the periodontal ligament.

Musculoskeletal symptoms are often the primary complaint prompting a patient to seek treatment. Chronic, forceful clenching and grinding lead to hypertrophy (enlargement) of the masticatory muscles, particularly the masseter and temporalis muscles, which may be palpable upon examination. This muscular overuse frequently results in myalgia (muscle pain), stiffness, and generalized facial fatigue, often worse upon waking. Furthermore, the repetitive, non-physiological loading of the temporomandibular joint (TMJ) can contribute significantly to the development or progression of temporomandibular disorders (TMDs), manifesting as clicking, popping, limited jaw opening, and joint pain (arthralgia).

Beyond oral and facial structures, bruxism is frequently associated with secondary symptoms that significantly diminish the patient’s quality of life. A hallmark symptom is the presence of chronic, dull tension headaches, particularly those localized in the temporal region and experienced early in the morning, reflecting nocturnal muscle strain. Other associated symptoms include earaches (otalgia), tinnitus (ringing in the ears), and dizziness. Sleep bruxism also severely impacts sleep continuity, not just for the patient, but often for the bed partner, who may report being frequently awakened or disturbed by the loud grinding sounds, highlighting the social dimension of this sleep disorder.

Diagnosis and Assessment

The diagnosis of bruxism relies on a combination of patient history, clinical examination, and objective instrumental assessment, as self-reporting, especially for sleep bruxism, is notoriously unreliable. The initial clinical examination involves a thorough inspection of the oral cavity for signs of chronic attrition, tongue indentations (scalloping), cheek biting (morsicatio buccarum), and palpable hypertrophy or tenderness in the masseter and temporalis muscles. A comprehensive history should investigate the presence of stress, anxiety, sleep quality, and the use of medications or substances known to influence jaw muscle activity.

For the definitive diagnosis and severity assessment of sleep bruxism, polysomnography (PSG) coupled with electromyography (EMG) of the masticatory muscles remains the gold standard. PSG/EMG allows researchers and clinicians to objectively monitor and quantify episodes of rhythmic masticatory muscle activity (RMMA) during sleep, correlating these events with specific sleep stages and micro-arousals. This objective data is crucial for differentiating true SB from other sleep-related movements and establishing a baseline for treatment effectiveness. A diagnosis of definite SB requires a specified number of RMMA episodes per hour of sleep, as defined by ICSD-3 criteria.

While PSG is definitive, simpler, less costly methods are often employed for screening and monitoring. These include standardized questionnaires (though prone to bias), the use of clinical indices (such as the Bruxism Status Examination), and the utilization of custom-fitted occlusal splints. While splints are primarily therapeutic, the characteristic wear patterns that develop on the acrylic surface after a period of use can provide indirect evidence of the location and force of grinding activity. Furthermore, portable EMG devices are increasingly used for ambulatory monitoring, providing objective data on muscle activity in the patient’s home environment, which is useful for diagnosing awake bruxism and monitoring treatment responses.

Psychological and Physical Comorbidities

Bruxism rarely exists in isolation and often presents with significant psychological and physical comorbidities, influencing both prognosis and treatment strategies. Psychologically, there is a substantial overlap between bruxism and various psychiatric diagnoses. Studies consistently demonstrate higher rates of generalized anxiety disorder (GAD), panic disorder, major depressive disorder, and traits such as perfectionism and hypervigilance among bruxism sufferers compared to the general population. This bidirectional relationship suggests that psychological distress may trigger bruxism as a coping mechanism, while the chronic pain and sleep disruption caused by bruxism can subsequently exacerbate underlying mood and anxiety disorders, creating a vicious cycle.

Physically, the strongest comorbidity exists with other sleep-related breathing disorders, most notably obstructive sleep apnea (OSA). The relationship between SB and OSA is complex; while some studies suggest OSA treatment may reduce SB, other evidence suggests that bruxism episodes, particularly clenching, may serve a protective physiological function. The forceful jaw movements associated with SB are sometimes interpreted as a response to airway collapse or hypopnea, temporarily increasing muscle tone to reposition the mandible and reopen the airway. Therefore, when SB is diagnosed, screening for underlying OSA is mandatory to ensure comprehensive patient management.

Other systemic associations include gastroesophageal reflux disease (GERD). Nocturnal reflux events can trigger generalized arousal responses, which in turn are linked to the onset of rhythmic masticatory muscle activity. Furthermore, certain neurological conditions, such as essential tremor, epilepsy, and neurodegenerative disorders like Parkinson’s disease, can feature bruxism as a motor manifestation, requiring specialized neurological evaluation. Recognition of these complex comorbidities is paramount, as effective management of bruxism often necessitates concurrent treatment of the primary underlying or associated systemic condition.

Treatment Modalities

The management of bruxism is typically palliative, focusing on minimizing damage, reducing associated pain, and addressing etiological factors, as a definitive cure for the central mechanism is often elusive. Dental appliances, specifically occlusal splints (night guards), represent the most common physical intervention. These custom-fitted devices, usually fabricated from hard acrylic resin, are designed to cover the biting surfaces of the teeth. Their primary function is protective—they absorb and dissipate the heavy occlusal forces, thereby preventing tooth wear and reducing the load on the TMJs. They also help to stabilize the occlusion and may provide biofeedback that slightly reduces muscle activity, although they do not necessarily eliminate the underlying habit.

Behavioral and psychological interventions are crucial, particularly for managing awake bruxism and the stress component of sleep bruxism. For AB, habit reversal training and cognitive awareness techniques are employed to teach the patient to recognize and interrupt clenching behavior throughout the day. For both types, stress management techniques, including relaxation exercises, mindfulness, and cognitive-behavioral therapy (CBT), help to mitigate the psychological triggers that exacerbate the condition. Biofeedback therapy, which uses auditory or tactile signals to alert the patient when their masticatory muscles exceed a certain threshold of activity, has shown efficacy in reducing the frequency and intensity of bruxism episodes.

Pharmacological approaches are generally reserved for severe, refractory cases or those where bruxism is clearly secondary to medication side effects. Muscle relaxants (e.g., benzodiazepines) or low doses of certain tricyclic antidepressants may be prescribed temporarily to reduce muscle tone and improve sleep continuity, though long-term use is discouraged due to dependency risks and side effects. A highly effective advanced treatment involves the injection of botulinum toxin (Botox) into the masseter and temporalis muscles. Botox works by temporarily paralyzing or weakening the injected muscles, significantly reducing the force and intensity of clenching and grinding, thereby alleviating associated pain and preventing further dental damage, offering relief typically lasting several months.